Porokeratosis Market Value Is Estimated to Reach USD 2.3 Bn by 2028, With 6.50% CAGR – Credence Research

Posted on
by

Porokeratosis Market Value Is Estimated to Reach USD 2.3 Bn by 2028, With 6.50% CAGR - Credence Research
Some of the major players in the market are Coherent Inc., Alma Lasers, Almirall, Allergan, Pfizer, Lumenis, Coty Inc., Cutera, Bioness Inc., Biogen, PhotoMedex Inc., Valeant Pharmaceuticals, Hologic Inc., IPG Photonics Corporation, IRIDEX Corp., Hoffman-La Roche Ltd., Biolase Inc., Angiodynamics Inc. and Beiersdorf AG, etc.

The latest market report published by Credence Research, Inc. “Global Porokeratosis Market: Growth, Future Prospects, and Competitive Analysis, 2016 – 2028”. The Global Porokeratosis Market generated revenue of around USD 1.6 billion in 2021 and is anticipated to grow a CAGR of over 6.50% during the forecast period from 2022 to 2028 to reach around USD 2.3 billion in 2028.

The need for laser therapy is increasing, kidney transplant cases are rising, developed nations have stronger reimbursement regulations, research costs are rising, and market traders are becoming more competitive, among other factors that will cause the worldwide porokeratosis market to expand. The market for porokeratosis is expanding due to greater awareness of the ailment and consumer demand for improved skin. Consumers are more likely to use porokeratosis therapy items and procedures if more global treatment ideas are shared. In industrialized countries, consumer knowledge of the disease’s cancerous progression is rising. Due to the demand for personal care items, the porokeratosis market will expand. It is sufficient to understand porokeratosis’ malignant progression through clinical observation. As a result, the need for porokeratosis treatments has increased. However, market expansion may be hindered by the high cost of laser equipment, a shortage of qualified physicians, adverse drug reactions, and poor healthcare systems in low- and middle-income countries. Because porokeratosis is a rare ailment, there is little knowledge of it globally, which poses a substantial obstacle for the market.

The global porokeratosis market is segmented into therapies, end users, and geography. Based on therapies, the porokeratosis market is categorized into topical 5-fluorouracil, topical vitamin D, imiquimod, retinoids, cryotherapy, laser therapy, and others. Based on the end user, the porokeratosis market is segmented into hospitals, clinics, diagnostic centers, and research and academic institutes. Based on geography, the porokeratosis market is segmented into North America, Europe, Asia Pacific, Latin America, the Middle East and Africa.

In 2021, North America will dominate the global porokeratosis market due to an increase in actinic porokeratosis cases and a rise in kidney transplants; the United States currently controls most of the porokeratosis industry. Porokeratosis affects about 10.68% of kidney transplant recipients. According to the National Kidney Foundation, Inc., around 17,000 kidney transplants were carried out in the United States in 2019. It is anticipated that the availability of top-notch diagnostic and therapeutic choices, considerable health expenditures, and the presence of great athletes will all help to grow the porokeratosis medical industry in the United States.

Let’s learn more with complete Table of Content, List of Figure & List of Table–Read more:  https://www.credenceresearch.com/report/porokeratosis-market

Why To Buy This Report-

  • The report provides a qualitative and quantitative analysis of the global porokeratosis market by segments, current trends, drivers, restraints, opportunities, challenges, and market dynamics with the historical period from 2016-2020, base year- 2021, and forecast period 2022-2028.
  • The report contains information related to the competitive landscape, like how the key players in the market are operating at a global, regional, and country level.
  • In-depth analysis of the global porokeratosis market segmentation based on the therapies and end users.
  • Major countries in each region with their import/export statistics.
  • The global porokeratosis market report also includes analyzing the global, regional, and country levels, key market trends, significant players analysis, market growth strategies, and key application areas.

Table Of Content- 

1. Preface

1.1. Report Description

1.1.1. Purpose of the Report

1.1.2. Target Audience

1.1.3. USP and Key Offerings

1.2. Research Scope

1.3. Research Methodology

1.3.1. Phase I – Secondary Research

1.3.2. Phase II – Primary Research

1.3.3. Phase III – Expert Panel Review

1.3.4. Approach Adopted

1.3.4.1. Top-Down Approach

1.3.4.2. Bottom-Up Approach

1.3.5. Assumptions

1.4. Market Segmentation

2. Executive Summary

2.1. Market Snapshot: Global Porokeratosis Market

2.2. Global Porokeratosis Market, By Therapies

2.3. Global Porokeratosis Market, By End-User

2.4. Global Porokeratosis Market, By Region

3. Market Dynamics & Factors Analysis

3.1. Introduction

3.1.1. Global Porokeratosis Market Value, 2016-2028, (US$ Bn)

3.2. Market Dynamics

3.2.1. Key Growth Trends

3.2.2. Market Drivers

3.2.3. Market Restraints

3.2.4. Market Opportunities

3.2.5. Major Industry Challenges

3.3. Attractive Investment Proposition,2021

3.3.1. Therapies

3.3.2. End-User

3.3.3. Geography

4. Premium Insights

4.1. STAR (Situation, Task, Action, Results) Analysis

4.2. Porter’s Five Forces Analysis

4.2.1. Threat of New Entrants

4.2.2. Bargaining Power of Buyers/Consumers

4.2.3. Bargaining Power of Suppliers

4.2.4. Threat of Substitute Types

4.2.5. Intensity of Competitive Rivalry

4.3. Value Chain Analysis

4.4. Therapies Analysis

4.5. Marketing Strategy Analysis

4.5.1. Direct Marketing

4.5.2. Indirect Marketing

4.5.3. Marketing Channel Development Trend

5. Market Positioning of Key Players, 2021

5.1. Company market share of key players, 2021

5.2. Competitive Benchmarking

5.3. Market Positioning of Key Vendors

5.4. Geographical Presence Analysis

5.5. Major Strategies Adopted by Key Players

5.5.1. Key Strategies Analysis

5.5.2. Mergers and Acquisitions

5.5.3. Partnerships

5.5.4. Product Launch

5.5.5. Geographical Expansion

5.5.6. Others

6. COVID 19 Impact Analysis

6.1. Global Porokeratosis Market Pre Vs Post COVID 19, 2019 – 2028

6.2. Impact on Import & Export

6.3. Impact on Demand & Supply

7. Global Internet of Things Market

7.1. Global Porokeratosis Market, by Therapies, 2016-2028(US$ Bn)

7.1.1. Overview

7.1.2. Global Porokeratosis Market, By Therapies, 2021 vs 2028 (in%)

7.1.3. Global Porokeratosis Market, By Topical 5- fluorouracil, 2016-2028 (US$ Bn)

7.1.4. Global Porokeratosis Market, By Topical Vitamin D, 2016-2028 (US$ Bn)

7.1.5. Global Porokeratosis Market, By Imiquimod, 2016-2028 (US$ Bn)

7.1.6. Global Porokeratosis Market, By Retinoids, 2016-2028 (US$ Bn)

7.1.7. Global Porokeratosis Market, By Cryotherapy, 2016-2028 (US$ Bn)

7.1.8. Global Porokeratosis Market, By Laser Therapy, 2016-2028 (US$ Bn)

7.1.9. Global Porokeratosis Market, By Others, 2016-2028 (US$ Bn)

7.2. Global Porokeratosis Market, by End-User, 2016-2028(US$ Bn)

7.2.1. Overview

7.2.2. Global Porokeratosis Market, By End-User, 2021 vs 2028 (in%)

7.2.3. Global Porokeratosis Market, By Hospitals, 2016-2028 (US$ Bn)

7.2.4. Global Porokeratosis Market, By Clinics, 2016-2028 (US$ Bn)

7.2.5. Global Porokeratosis Market, By Diagnostic Centres, 2016-2028 (US$ Bn)

7.2.6. Global Porokeratosis Market, By Research and academic Institutes, 2016-2028 (US$ Bn)

8. North America Porokeratosis Market Analysis

……………

9. Europe Porokeratosis Market Analysis

…………….

10. Asia Pacific Porokeratosis Market Analysis

…………….

11. Latin America Porokeratosis Market Analysis

……………..

12. Middle East and Africa Porokeratosis Market Analysis

12.1. Middle East and Africa Porokeratosis Market, by Therapies, 2016-2028(US$ Bn)

12.1.1. Overview

12.1.2. SRC Analysis

12.2. Middle East and Africa Porokeratosis Market, by End-User, 2016-2028(US$ Bn)

12.2.1. Overview

12.2.2. SRC Analysis

12.3. Middle East and Africa Porokeratosis Market, by Country, 2016-2028 (US$ Bn)

12.3.1. GCC Countries

12.3.1.1. GCC Countries il Porokeratosis Market Estimates and Forecast, 2016-2028 (US$ Bn)

12.3.1.2. GCC Countries Porokeratosis, By Therapies, 2016-2028 (US$ Bn)

12.3.1.3. GCC Countries Porokeratosis, By End-User, 2016-2028 (US$ Bn)

12.3.2. South Africa

12.3.2.1. South Africa Porokeratosis Market Estimates and Forecast, 2016-2028 (US$ Bn)

12.3.2.2. South Africa Porokeratosis, By Therapies, 2016-2028 (US$ Bn)

12.3.2.3. South Africa Porokeratosis, By End-User, 2016-2028 (US$ Bn)

12.3.3. Rest of Middle East and Africa

12.3.3.1. Rest of Middle East and Africa Porokeratosis Market Estimates and Forecast, 2016-2028 (US$ Bn)

12.3.3.2. Rest of Middle East and Africa Porokeratosis, By Therapies, 2016-2028 (US$ Bn)

12.3.3.3. Rest of Middle East and Africa Porokeratosis, By End-User, 2016-2028 (US$ Bn)

13. Company Profiles

13.1. Coherent Inc.

13.1.1. Company Overview

13.1.2. Products/Services Portfolio

13.1.3. Geographical Presence

13.1.4. Financial Summary

13.1.4.1. Market Revenue and Net Profit (2019-2021)

13.1.4.2. Business Segment Revenue Analysis

13.1.4.3. Geographical Revenue Analysis

13.2. Alma Lasers

13.3. Almirall

13.4. Allergan

13.5. Pfizer

13.6. Lumenis

13.7. Coty Inc.

13.8. Cutera, Bioness Inc.

13.9. Biogen

13.10. PhotoMedex Inc.

13.11. Valeant Pharmaceuticals, Hologic Inc.

13.12. IPG Photonics Corporation

13.13. IRIDEX Corp.

13.14. Hoffman-La Roche Ltd.

13.15. Biolase Inc.

13.16. Angiodynamics Inc.

13.17. Beiersdorf AG

………………

Let’s learn more with complete Table of Content, List of Figure & List of Table–Read more:  https://www.credenceresearch.com/report/porokeratosis-market

About Us

Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, nonlegislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.

Top Selling Reports @

Transverse Myelitis Treatment Market By Treatment type (Intravenous steroids, Plasma exchange therapy, Antiviral medication, Others) By Route of administration (Oral, Parenteral, Others) By End-users (Hospitals, Homecare, Speciality clinics, Others) By Distribution channels (Hospital pharmacy, Online pharmacy, Retail pharmacy) – Growth, Share, Opportunities & Competitive Analysis, 2016 – 2028

Drugs For Schistosomiasis Market By Drug Type (Artemisinins, Biltricide, Corticosteroids, Metrifonate, Trioxolanes, Praziquantel, Oxamniquine, Others) By Application (Schistosoma Guineensis, Schistosoma Haematobium, Schistosoma Intercalatum, Schistosoma Japonicum, Schistosoma Mansoni, Schistosoma Mekongi) By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)- Growth, Size, Share and Competitive Analysis 2015 – 2027

Media Contact
Company Name: Credence Research
Contact Person: Chris Smith
Email: Send Email
Phone: 18003618290
City: SAN JOSE
State: CA
Country: United States
Website: https://www.credenceresearch.com/